Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 10.

Journal Article

Delev, Daniel ORCID: 0000-0001-9444-0178, Heiland, Dieter Henrik, Franco, Pamela, Reinacher, Peter ORCID: 0000-0003-1691-546X, Mader, Irina, Staszewski, Ori ORCID: 0000-0002-0579-6701, Lassmann, Silke, Grau, Stefan and Schnell, Oliver (2019). Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system. J. Neuro-Oncol., 141 (1). S. 223 - 234. NEW YORK: SPRINGER. ISSN 1573-7373

Golla, Heidrun, Nettekoven, Charlotte ORCID: 0000-0002-8944-4681, Bausewein, Claudia, Tonn, Joerg-Christian, Thon, Niklas, Feddersen, Berend, Schnell, Oliver, Boehlke, Christopher ORCID: 0000-0002-6985-0201, Becker, Gerhild, Rolke, Roman, Clusmann, Hans, Herrlinger, Ulrich, Radbruch, Lukas, Vatter, Hartmut, Gueresir, Erdem, Stock, Stephanie, Mueller, Dirk, Civello, Daniele, Papachristou, Irini, Hellmich, Martin, Hamacher, Stefanie ORCID: 0000-0003-2158-9101, Voltz, Raymond and Goldbrunner, Roland (2020). Effect of early palliative care for patients with glioblastoma (EPCOG): a randomised phase III clinical trial protocol. BMJ Open, 10 (1). LONDON: BMJ PUBLISHING GROUP. ISSN 2044-6055

Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Haenel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Ruediger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tuettenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin (2016). Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. J. Clin. Oncol., 34 (14). S. 1611 - 1623. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortman, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Tabatabai, Ghazaleh, Ringel, Florian, Schmidt-Graf, Friederike, Brehmer, Stefanie, Weyerbrock, Astrid, Bullinger, Lars, Vajkoczy, Peter, Vatter, Hartmut, Schaefer, Niklas, Kebir, Sied, Weller, Johannes, Stummer, Walter, Simon, Matthias, Keil, Vera ORCID: 0000-0001-8699-3506, Nelles, Michael, Fimmers, Rolf, Pietsch, Torsten, Hattingen, Elke, Coch, Christoph and Glas, Martin (2017). PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. Neuro-Oncology, 19. S. 13 - 15. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Herrlinger, Ulrich, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter ORCID: 0000-0003-3894-5053, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schaefer, Niklas, Kebir, Sied, Weller, Johannes ORCID: 0000-0001-5818-5392, Schaub, Christina, Stummer, Walter, Tonn, Joerg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang ORCID: 0000-0002-6171-634X, Weller, Michael, Fimmers, Rolf, Schmid, Matthias ORCID: 0000-0002-0788-0317, Hattingen, Elke ORCID: 0000-0002-8392-9004, Pietsch, Torsten, Coch, Christoph and Glas, Martin (2019). Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. Lancet, 393 (10172). S. 678 - 689. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1474-547X

Jansen, Elena, Hamisch, Christina, Ruess, Daniel, Heiland, Dieter Henrik, Goldbrunner, Roland, Ruge, Maximilian I., Schnell, Oliver and Grau, Stefan J. (2019). Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification. J. Neuro-Oncol., 145 (3). S. 501 - 508. NEW YORK: SPRINGER. ISSN 1573-7373

Karschnia, Philipp ORCID: 0000-0002-1254-5310, Young, Jacob S., Dono, Antonio ORCID: 0000-0002-8041-8399, Haeni, Levin, Sciortino, Tommaso, Bruno, Francesco ORCID: 0000-0001-8087-5293, Juenger, Stephanie T., Teske, Nico, Morshed, Ramin A., Haddad, Alexander F., Zhang, Yalan, Stoecklein, Sophia, Weller, Michael ORCID: 0000-0002-1748-174X, Vogelbaum, Michael A., Beck, Juergen, Tandon, Nitin, Hervey-Jumper, Shawn, Molinaro, Annette M., Ruda, Roberta, Bello, Lorenzo, Schnell, Oliver, Esquenazi, Yoshua, Ruge, Maximilian, I, Grau, Stefan J., Berger, Mitchel S., Chang, Susan M., van den Bent, Martin and Tonn, Joerg-Christian . Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro-Oncology. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Karschnia, Philipp ORCID: 0000-0002-1254-5310, Young, Jacob S., Dono, Antonio ORCID: 0000-0002-8041-8399, Hani, Levin, Juenger, Stephanie T., Sciortino, Tommaso, Bruno, Francesco ORCID: 0000-0001-8087-5293, Teske, Nico, Morshed, Ramin A., Haddad, Alexander F., Zhang, Yalan, Stoecklein, Sophia, Vogelbaum, Michael A., Beck, Juergen, Tandon, Nitin, Hervey-Jumper, Shawn, Molinaro, Annette M., Ruda, Roberta, Bello, Lorenzo, Schnell, Oliver, Esquenazi, Yoshua, Ruge, Maximilian, I, Grau, Stefan J., van den Bent, Martin, Weller, Michael ORCID: 0000-0002-1748-174X, Berger, Mitchel S., Chang, Susan M. and Tonn, Joerg-Christian (2022). TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group. Neuro-Oncol. Adv., 4 (1). OXFORD: OXFORD UNIV PRESS. ISSN 2632-2498

Schaefer, Niklas, Proescholdt, Martin, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter ORCID: 0000-0003-3894-5053, Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Grau, Stefan, Haenel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh ORCID: 0000-0002-3542-8782, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Niessen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin and Herrlinger, Ulrich (2018). Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Neuro-Oncology, 20 (7). S. 975 - 986. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866

Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael ORCID: 0009-0000-1485-7820, Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Gueresir, Erdem, Schmid, Matthias ORCID: 0000-0002-0788-0317, Schuss, Patrick ORCID: 0000-0002-5806-2576, Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank ORCID: 0000-0003-4892-6104, Herrlinger, Ulrich and Schneider, Matthias (2022). Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. Trials, 23 (1). LONDON: BMC. ISSN 1745-6215

This list was generated on Sat Apr 20 16:14:16 2024 CEST.